Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-01-03
1992-08-25
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
546167, A01N 5502, C07D40104
Patent
active
051419319
ABSTRACT:
6-Alkyl-5-(6, or 7-quinolinyl)-3-(substituted)-2(1H)-pyridinones useful as cardiotonics are synthesized by reaction of trialkylquinolinylstannanes with 6-alky-5-halo-3-(substituted)-2(1H)-pyridinones. Compositions containing these pyridinones and methods of using them to treat congestive heart failure are provided.
REFERENCES:
patent: 4313951 (1982-02-01), Lesher et al.
patent: 4517192 (1985-05-01), Lesher
patent: 4559352 (1985-12-01), Lesher et al.
patent: 4595762 (1986-06-01), Lesher et al.
patent: 4710507 (1987-12-01), Campbell
patent: 4785005 (1988-11-01), Campbell et al.
Chemical Abstracts, vol. 109 No. 11, #92799n, 1987, Gil et al., "Preparation of pyridinone derivatives as cordiotonic agents".
Echavarren and Stille, "Palladium-Catalyzed Coupling of Aryl Triflates with Organostannanes", J. Am. Chem. Soc. 109:5478-5486 (1987).
Covington Raymond
DuPont Paul E.
Hansen Philip E.
Ivy C. Warren
Sterling Winthrop Inc.
LandOfFree
5-Quinolinylpyridinones, cardiotonic compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-Quinolinylpyridinones, cardiotonic compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-Quinolinylpyridinones, cardiotonic compositions and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-385117